Previous 10 | Next 10 |
Search all stock news releases related news releases and press releases from US and Canada Markets.
WILMINGTON, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its second quarter ended February 24, 2024 as compared to the corresponding period in the prior fiscal ye...
GRAND JUNCTION, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- (OTCQB: MAPPF) (TSXV: MAPS) (FSE: 5D00) ProStar Holdings Inc. (the "Company" or "ProStar ® ") a world leader in Precision Mapping Solutions ® , is pleased to announce that it has closed the first tranche of its previously...
GRAND JUNCTION, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- (OTCQB: MAPPF) (TSXV: MAPS) (FSE: 5D00) ProStar Holdings Inc. (the "Company" or "ProStar ® ") a world leader in Precision Mapping Solutions ® , is pleased to announce that it has closed the first tranche of its previously...
2024-03-27 08:00:02 ET Greg McGinniss from Scotiabank issued a price target of $27.00 for COLD on 2024-03-27 06:36:00. The adjusted price target was set to $27.00. At the time of the announcement, COLD was trading at $24.68. The overall price target consensus is at $34.6...
New Provectus Spinout Company Would Commercialize Combination Therapy of University’s Light Source Medical Device and Provectus’s Pharmaceutical-Grade Rose Bengal Sodium KNOXVILLE, TN, March 27, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus...
Receives Determination Letter from FDA Stating AXIOFILL Does Not Qualify for Classification as an HCT/P Under Section 361 MIMEDX Continues to Pursue All Available Options to Keep AXIOFILL on the Market Reiterates Expectations for 2024 Net Sales Percentage Growth in the Low Doubl...
–PRIME status is supported by positive data from the Phase 2b ENLIVEN trial of pegozafermin– –Phase 3 ENLIGHTEN-Fibrosis trial in non-cirrhotic MASH (fibrosis stage F2-F3) patients is enrolling and ENLIGHTEN-Cirrhosis in MASH patients with compensated cirrhosis (F4)...
AUSTIN, Texas, March 27, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, toda...
Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - March 27, 2024) - Investorideas.com , a go-to investing platform covering defense and energy stocks releases a news report on recent contract news and contracts within the defense industry, featuring KULR Technology Group, Inc ...
WNS (Holdings) Limited (NYSE: WNS), a leading provider of global digital-led Business Process Management (BPM) solutions, today announced that it has been recognized as a ‘Leader’ and a ‘Star Performer’ in Everest Group’s 2024 Financial Crime and Compliance (FCC...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
19.15%Change Percent:
TransCode Therapeutics Inc. Company Name:
RNAZ Stock Symbol:
NASDAQ Market: